A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2002
12/12/2002	WO2002002775A3 Calpain protease 12
12/12/2002	WO2001097786A3 Benzothiazole derivatives
12/12/2002	WO2001097607A3 Transgenic animal model of neurodegenerative disorders
12/12/2002	WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	US20020188128 Substituted imidazo[1,2-A] pyridine derivatives
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002	US20020188025 Compositions for promoting sleep
12/12/2002	US20020188022 Methods for modulation, stimulation, and inhibition of glutamate reuptake
12/12/2002	US20020188020 Aminoindan derivatives
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020188017 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002	US20020188007 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
12/12/2002	US20020188006 4-hydroxypiperidine derivatives having antiarrhythmic activity
12/12/2002	US20020188003 Cocaine receptor binding ligands
12/12/2002	US20020188002 Pharmaceutical composition based on cocaethylene and use thereof for treating psychoactive substance dependence
12/12/2002	US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187996 Prevention of addiction in pain management
12/12/2002	US20020187994 New compounds
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002	US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187941 Pregabalin lactose conjugates
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002	US20020187934 Peptide derivatives
12/12/2002	US20020187931 Modulating cell survival by modulating huntingtin function
12/12/2002	US20020187928 Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors
12/12/2002	US20020187920 Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder
12/12/2002	US20020187542 Fatty-acid amide hydrolase
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187192 Pharmaceutical composition which reduces or eliminates drug abuse potential
12/12/2002	US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002	DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449752A1 Method of identifying a polymorphism in cyp2d6
12/12/2002	CA2449175A1 Use of methylnaltrexone to treat immune suppression
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449077A1 Epothilone derivatives
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002	CA2448665A1 Sustained-release analgesic compounds
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2447746A1 Cycloalkenylsulfonamide derivatives
12/12/2002	CA2446716A1 Sulfonamide derivatives
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	CA2446160A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
12/12/2002	CA2438099A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/12/2002	CA2418088A1 Numb protein expression inhibitors by musashi 1
12/11/2002	WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum
12/11/2002	EP1264887A1 Novel armadillo repeat-containing protein alex1
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264183A2 Diagnosis and treatment of vascular dementia
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom
12/11/2002	EP1263930A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002	EP1263774A2 Gamma-secretase inhibitors
12/11/2002	EP1263768A2 Chimeric neuropeptide y receptors
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263753A1 Imidazol derivatives as raf kinase inhibitors
12/11/2002	EP1263750A1 Method for the preparation of citalopram
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis

1 ... 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 ... 1833